Molecule Details
| InChIKey | WRBFEBQSRXUQAA-MKSAFVGPSA-N |
|---|---|
| Compound Name | (2S,3R,4R,5S,6R)-2-[3-[[4-[(3R)-1-[(3R,5S,6R)-5-amino-6-(2,5-difluorophenyl)oxan-3-yl]pyrrolidin-3-yl]oxyphenyl]methyl]-4-propan-2-ylphenyl]-6-methylsulfanyloxane-3,4,5-triol |
| Canonical SMILES | CS[C@H]1O[C@@H](c2ccc(C(C)C)c(Cc3ccc(O[C@@H]4CCN([C@H]5CO[C@H](c6cc(F)ccc6F)[C@@H](N)C5)C4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.55 |
| Source | BindingDB |
2D Structure
Activity Profile